ArticleEuropean clinical respiratory journal2026
Effects of long-term, home-based, virtual cycling after COPD exacerbation - results from the randomised controlled COPDtoParis trial.
Article in European clinical respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issuedCorrection.2026
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with functional decline, reduced quality of life, and high rates of readmission and mortality. Although exercise is recommended following AECOPD, long-term adherence and maintenance of benefits remain challenging. Home-based, technology-supported exercise modalities may offer accessible alternatives, but evidence on long-term effectiveness remains limited. Objective: To evaluate the effectiveness of a long-term, home-based, virtual cycling intervention on physical performance, physical activity, lung function, functional mobility, frailty, symptoms, health-related quality of life (HRQoL), and hospital readmission in people with COPD following AECOPD. Methods: This single-centre, parallel-group, cluster randomised controlled trial recruited patients hospitalised with AECOPD. Participants were randomised in teams to 12 months of home-based virtual cycling or standard care. The intervention consisted of team-based cycling on pedal trainers guided by pre-recorded route videos. The primary outcome was the five-repetition sit-to-stand test (5RSTS). Secondary outcomes included physical performance, lung function, physical activity measured by leg-mounted triaxial accelerometers, dyspnoea, frailty, functional mobility, and HRQoL. Outcomes were assessed at baseline, 6 weeks, 6 months, and 12 months using linear mixed models. Results: Forty participants were randomised (21 intervention, 19 control). Physical and respiratory outcomes remained largely stable over time with no significant between-group differences. At 12 months, the intervention group reported higher self-rated health and functional mobility compared with controls in secondary outcomes. Sedentary time remained high in both groups, and readmission and mortality rates were similar. Conclusion: In older, multimorbid individuals recovering from AECOPD, long-term home-based virtual cycling did not improve physical performance, activity levels, or lung function, but was associated with higher self-perceived health and functional mobility at 12 months. However, given attrition and limited power, these findings should be cautiously interpreted. Low-threshold, technology-supported exercise may offer patient-centred benefits in populations with limited exercise reserve but research with sufficient power is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.